Biotech RadarJobs updated

COMPANY

HotSpot Therapeutics

HQ: Boston, MA (US office) source · hotspotthera.com ↗

Clinical Phase 2

Keywords: immunology autoimmune diseases cutaneous lupus erythematosus rheumatoid arthritis HST-1011

Location: Boston, MA (US office) · source · Oct 15, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)

Timeline

  1. Trial start Phase 1/Phase 2: A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody source ↗

Clinical trials (lead sponsor) 1

RecordTitlePhaseStatusStartPrimary completion
NCT05662397A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 AntibodyPhase 1/Phase 2Active, not recruitingMar 15, 2023Dec 31, 2025 (estimated)

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

Feedback